Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada

Prot-Labarthe, Sonia; Bussieres, Jean-Francois; Barett, Pierre; Bourdon, Olivier; Brion, Francoise

Abstract

Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada

Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise

Issue: Jul/Aug 2008 - Hormone Replacement Therapy

View All Articles in Issue

Page(s): 365-367

Download in electronic PDF format for $75

Abstract

There are a limited number of commercial oral pediatric drug formulations on the market. The incidence of available commercial oral formulations for children has not been studied to date. This study compared the number and the characteristics of oral pediatric drug formulations listed on two hospital group purchasing agreements for the two large urban areas (e.g., Paris and Montreal), valid on April 1, 2006. Variables collected were the brand and the generic name product, the anatomical therapeutic chemical classification, the drug formulation, and the dispensing tool. Throughout this study, we identified that there was a total of 191 and 151 commercial oral pediatric drug formulations corresponding to 127 and 94 generic name products, respectively in Paris and Montreal. The three main anatomical therapeutic chemical classification classes are alimentary tract and metabolism drugs, systemic anti-infectives, and drugs acting on nervous system. There are only 47 generic names common to both group purchasing agr

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
May/Jun 2007 Pg. 220-225	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Nov/Dec 2022 Pg. 516-521	Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Jan/Feb 2001 Pg. 6-8	Pediatric Compounding: Coloring Outside the Lines Author(s): Preckshot John
Jul/Aug 2008 Pg. 372-374	Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Sep/Oct 2006 Pg. 390	Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Nov/Dec 2005 Pg. 423-431	Compounding for a Pediatric Hospital Author(s): McElhiney Linda F
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 1998 Pg. 35-37	The Formulation and Use of Placebo Dosage Forms in Pharmacy Author(s): Al-Achi Antoine, Greenwood Robert
Mar/Apr 2017 Pg. 105-108	Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students Author(s): Benischek Rita
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Jan/Feb 2001 Pg. 9-12	Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Author(s): Schotik Debora
Jan/Feb 2010 Pg. 32-38	Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting Author(s): McElhiney Linda F
Mar/Apr 2008 Pg. 116-120	Establishing a Quality-Assurance Program for Hospital Compounding Author(s): McElhiney Linda F
Jan/Feb 2009 Pg. 14-18	Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Author(s): Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
Jul/Aug 2011 Pg. 268	PreScription: The Science and Technology of Hospital Pharmacy Newsletter Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 224-229	Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education Author(s): McElhiney Linda F